Deep penetration of nanocarriers into solid tumours remains a major challenge in cancer nanomedicine due to the complex tumour microenvironment (TME) and associated physiological barriers. This review examines nanocarrier strategies...
Bobrin et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: